Series D Financing

Wire

SpyGlass Pharma secures $75 million Series D financing
ByNNR June 2, 2025June 2, 2025

LOS ANGELES: SpyGlass Pharma has closed a $75 million Series D financing round to advance its ophthalmic Drug Delivery Platform, the company announced Monday. The round was led by Sands Capital, with participation from Gilde Healthcare and existing investors, including…

Read More SpyGlass Pharma secures $75 million Series D financing
London Exchange

Vedanta Biosciences completes $68 million Series D Financing
ByNNR July 21, 2021October 24, 2023

LONDON, UK: PureTech Health plc , a clinical-stage biotherapeutics company announces that its Founded Entity, Vedanta Biosciences completed a $68 million Series D financing. Vedanta plans to use the proceeds to advance its pipeline of defined bacterial consortia, including progressing VE303…

Read More Vedanta Biosciences completes $68 million Series D Financing